Fluidigm Singapore launches Biomedical Product Development Centre

Singapore R&D center to develop life science instruments targeted for US$650 million market

05-Feb-2007

Fluidigm accelerates its R&D and manufacturing activities in Singapore, through the launch of its new Biomedical Product Development Center. This center, a core part of Fluidigm's worldwide R&D organization, will be responsible for the full development of a Fluidigm BioMark II series of instrumentation.

The center's initial research activities will support the development of instrumentation for the BioMark II system. The Singapore research group will undertake 100% of the R&D on a new biochip fluorescence reader and biochip loader, specially designed for high-throughput genotyping and protein expression applications. Fluidigm Singapore will also manufacture the BioMark II system.

Operations for the Biomedical Product Development Center will commence immediately, with its current R&D team of 5. Additional staff will be recruited from Singapore's pool of manufacturing and research expertise. The R&D center will also be supported by the local precision engineering companies, academic, biomedical and pharmaceuticals research institutions.

Other news from the department manufacturing

Most read news

More news from our other portals

Is artificial intelligence revolutionizing the life sciences?

Last viewed contents

Immune responses to flu vaccine are diminished in lupus patients

Merck Furthers Commitment Towards Elimination of Schistosomiasis - Public-private partnership in Australia and the US

Merck Furthers Commitment Towards Elimination of Schistosomiasis - Public-private partnership in Australia and the US

Siegfried (USA) Inc. and Jazz Pharmaceuticals sign Supply Agreement

Amyloid formation may link Alzheimer disease and type 2 diabetes

BioFocus and InterMed Discovery Announce Marketing Collaboration

Biocrea announces novel treatment opportunities for CNS diseases - Company has filed US patent on novel, brain-penetrating PDE2 and PDE10 inhibitors

Discovery of a potential new therapy for inflammatory arthritis - Researchers at the Schroeder Arthritis Institute in Toronto have made a discovery that could lead to new treatments for axial spondyloarthritis.

Discovery of a potential new therapy for inflammatory arthritis - Researchers at the Schroeder Arthritis Institute in Toronto have made a discovery that could lead to new treatments for axial spondyloarthritis.

Deadly combination: new direct trigger for cell death discovered - Understanding the basic mechanisms that lead to cell death is essential for the development of therapies for cancer and other diseases

Deadly combination: new direct trigger for cell death discovered - Understanding the basic mechanisms that lead to cell death is essential for the development of therapies for cancer and other diseases

Deuterium Depletion: A New Concept in Anticancer Drug Development

So-called junk DNA plays critical role in mammalian development - Knocking out transposon promoter leads to pup death in mice; similar promoters found in many mammals

So-called junk DNA plays critical role in mammalian development - Knocking out transposon promoter leads to pup death in mice; similar promoters found in many mammals

Leprosy strain genotyped from medieval pilgrim at UK burial site - Medieval leprosy victim in UK cemetery was likely a religious pilgrim, possibly from overseas

Biological wires carry electricity thanks to special amino acids